Capvis has acquired a majority stake in Arag
Capvis AG has acquired a majority stake in Arag Srl.
Headquartered in Switzerland, Capvis is one of the leading private equity players in Europe. It generates sustainable value and offers a highly professional team of international specialists with comprehensive experience, providing a corporate culture that combines engagement with success.
Arag, founded in 1976 and based in Rubiera, Italy, is active in the production and marketing of components and accessories for spraying and agriculture. The company’s portfolio has over 3,600 products, including monitoring systems, nozzles, tank lids, valves and filters. Arag sells its products in over 110 countries and has approximately 500 employees. The company has three offices in Italy and branches in Australia, Argentina, Brazil and Bulgaria. Over 85% of Arag’s revenues are generated abroad.
Oaklins’ team in Italy supported Capvis as financial advisor. Banco BPM provided the acquisition financing.
Talk to the deal team
Related deals
ABZ Seeds has been acquired by Planasa
ABZ Seeds, a renowned breeder of seed-propagated F1 hybrid strawberry varieties, has been acquired by Planasa, a global leader in breeding next-generation berry varieties, including blueberries, blackberries, raspberries and strawberries.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more